44. Ethical Care Guidelines for GLP-1s: Body Autonomy, Informed Consent, and Anti-Fat Bias
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
Summary
On this episode of The Body Trust Podcast, Hilary, Sirius and Dana discuss the intentions behind their free ethical care guidelines for GLP-1 medications. They critique weight-centric healthcare, industry-influenced research, and an “ethics” focus limited to rationing and allocation rather than relational care, informed consent, and “do no harm.” Centering body autonomy, they stress that true consent requires unbiased information and freedom from coercion, including weight stigma and medical gaslighting. They highlight risks such as deaths, weight cycling, and inadequate eating-disorder screening, including concerns about people developing or worsening eating disorders on GLP-1s. They describe practical elements of weight-inclusive care, identify clinical red flags, and encourage patients and providers to use the guidelines to ask better questions while recognizing systemic anti-fat bias cannot be solved by individual weight loss.
RESOURCES
Ethical Care Guidelines for GLP1 Medications by Center for Body Trust
Freedom & Desire Substack by Sirius Bonner
Coaching with Meg Bradbury
Certified Body Trust Provider Directory
Are you tired of “weighting” to live your life? Our beloved No More Weighting program is a self-paced e-course to introduce you to Body Trust. It is available for purchase now! Learn more here.
Looking for Body Trust training? Our Groundwork training starts the day you purchase it. Learn more here.
For more on all of our offerings, click here.
Send us your thoughts/questions.
CONNECT WITH US
Support The Podcast
Newsletter
Website
Produced by Wowow Podcasts